Anderson did not identify the member or members of the "COX-2
chemistry team" who requested that the testing be performed.
The Huang and Reitz testimony
Dr. Huang testified that he submitted SC-58394 to
Koboldt for "biological testing" (Exh. 2018 at ¶9). Dr. Huang
did not testify that he submitted any other compounds
synthesized by himself or Dr. Chamberlain for testing to
establish utility.
Dr. Reitz did not testify that he submitted any compound
synthesized by Dr. Huang, Dr. Chamberlain, or himself, for
biological testing to establish utility. Neither Dr. Huang
nor Dr. Reitz testified that he directed Dr. Chamberlain to
perform any syntheses or testing of compounds within the scope
of the count.
The Chamberlain testimony
Dr. Chamberlain testified that he was asked by Dr. Reitz
to synthesize several diphenylbenzofurans "for testing of
their
anti-inflammatory activity as COX-2 inhibitors" (Exh. 2019
at ¶2); however, we have not been pointed to evidence of
record that establishes that Dr. Chamberlain requested the
Koboldt, Veenhuizen, or Anderson testing at the explicit or
27
Page: Previous 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 Next
Last modified: November 3, 2007